Venous Leg Ulcers Treatment and Management: Understanding Chronic Venous Insufficiency and Venous Leg Ulcers
More than 80 million Americans have vein disease, including chronic venous insufficiency (CVI). In fact, 40% of women and 20% of men have significant problems by age 50 years. These disorders have a very high rate of recurrence and can develop into more serious conditions such as venous leg ulcers (VLUs). VLU care is estimated at $3 billion annually, thus making it a significant burden on the health care system, but the costs are also high in terms of patients’ quality of life. Understanding the causes, risk factors, and options for comprehensive management is critical to reducing the risk of complications, optimizing outcomes for patients, and minimizing costs.
This guide is part one in series on VLU management, and provides background information on the prevalence, causes, costs, and risks of these wounds, as well as a CVI classification system. It also discusses current best practice treatment options for both CVI and VLUs, including the BSN Medical integrated therapeutic system that removes exudate and bacteria, rebuilds tissue, reduces edema with compression therapy, and prevents recurrence.
Health care professionals whose patients are at risk for CVI or already have CVI and VLUs will find this guide a helpful resource for creating an integrated and comprehensive care plan of treatment for these patients to facilitate healing and improve overall health and mobility.
Part two of the series will be released in October 2018.
The following topics are discussed:
This white paper is generally written for wound care providers and other health care professionals with an interest in venous leg ulcer treatment and management.
Sponsored by BSN Medical, an Essity Company